To start a drug clinical trial in Japan, you need the following documentation: Clinical Trial Notification (CTN), protocol, investigator’s brochure, informed consent forms, ethical committee approval, Good Clinical Practice (GCP) compliance, and preclinical data. Additionally, submit to the Pharmaceuticals and Medical Devices Agency (PMDA) for review and approval.
